IPSS score for primary myelofibrosis
Risk stratification in primary myelofibrosis
Low risk
Median survival: 11.3 years
NaN
További információk
Figyelmeztetés
Ez az eszköz kizárólag oktatási célra szolgál, és nem jelent vagy helyettesít szakmai tanácsot. Az eszköz nem használható orvosi diagnózis felállítására és/vagy orvosi kezelés nyújtására.
General description
The International Prognostic Scoring System consists of five predictors of shortened survival in patients with primary myelofibrosis (PMF). Based on the number of present predictors patients are stratified into 4 risk groups with median survivals of 11.3, 7.9, 4.0, and 2.3 years.
The International Prognostic Scoring System consists of five predictors of shortened survival in patients with primary myelofibrosis (PMF). Based on the number of present predictors patients are stratified into 4 risk groups with median survivals of 11.3, 7.9, 4.0, and 2.3 years.
Reference values
Low risk
0 pointsIntermediate-1 risk
1 pointsIntermediate-2 risk
2 pointsHigh risk
≥ 3 pointsReference
Cervantes F, Dupriez B, Pereira A et al. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood 2009; 113: 2895–2901.
Vannucchi AM, Barbui T, Cervantes F, et al. Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 26 (Supplement 5): Annals of Oncology 26 (Supplement 5): 2015:v85–v99.
Verzió
1
Az eszközről
The International Prognostic Scoring System consists of five predictors of shortened survival in patients with primary myelofibrosis (PMF). Based on the number of present predictors patients are stratified into 4 risk groups with median survivals of 11.3, 7.9, 4.0, and 2.3 years.
